Z-2105-2021 Class II Terminated
FDA device recall Z-2105-2021 was initiated by Cell Marque Corporation on May 27, 2021 and is designated Class II. Reason for recall: Product distributed for use as an In-vitro Diagnostics without FDA clearance The recall status is terminated (terminated Apr 5, 2024). Affected quantity: 41 kits.
Recall details
- Product Type
- Devices
- Report Date
- Jul 28, 2021
- Initiation Date
- May 27, 2021
- Termination Date
- Apr 5, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 41 kits
Product description
Cell Marque, RabMAb,CD17, c-kit (YR145) Rabbit Monoclonal Primary Antibody, REF: 117R-18, IVD, CE, GTIN: 00841683123798
Reason for recall
Product distributed for use as an In-vitro Diagnostics without FDA clearance
Distribution pattern
US: AL, AR, AZ, CA, FL, HI, ID, IL, KY, MN, MT, NC, NH, NY, PA, SC, VA, WI OUS: N/A
Code information
Lot Numbers: 0000058081/ Exp: 31 Dec 2021, 0000072580/ Exp: 30 Sep 2021, 0000090505/ Exp: 30 Sep 2022, 0000121052/ Exp: 31 May 2023
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2105-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026